Trial ID or NCT#



not recruiting iconNOT RECRUITING


To evaluate the safety and effectiveness of the Model 400 aortic valve bioprosthesis.

Official Title

Medtronic PERIcardial SurGical AOrtic Valve ReplacemeNt Pivotal Trial A Multi-center, Non-randomized Trial to Determine the Safety and Effectiveness of the Model 400 Aortic Valve Bioprosthesis in Patients With Aortic Valve Disease

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Michael Fischbein
Michael Fischbein
Cardiothoracic surgeon
Associate Professor of Cardiothoracic Surgery (Adult Cardiac Surgery)

Contact us to find out if this trial is right for you.


Kokil Bakshi
(650) 498-1232